Literature DB >> 11264136

A simple corneal perfusion chamber for drug penetration and toxicity studies.

M A Thiel1, N Morlet, D Schulz, H F Edelhauser, J K Dart, D J Coster, K A Williams.   

Abstract

AIMS: Corneal perfusion chambers are important tools in the development and assessment of ophthalmic drugs. The aim of this study was to design and test a modified perfusion chamber suitable for topical application of drugs to isolated corneoscleral preparations, and which allowed continuous monitoring of endothelial cell function.
METHODS: A polycarbonate and stainless steel perfusion chamber was designed to clamp corneas in a horizontal plane suitable for topical drug delivery. Endothelial cell function was assessed by ultrasonic pachymetry and specular microscopy during perfusion. Epithelial barrier function was assessed by penetration of fluorescein. Leakage was examined by measuring penetration of a large protein, IgG. Tissue architecture after perfusion was examined by conventional histology.
RESULTS: Corneas maintained a functionally and morphologically intact endothelial monolayer during perfusion periods of up to 14 hours. The epithelial barrier function was well preserved. The tissue clamp sealed the preparation effectively against leakage of macromolecules.
CONCLUSION: The new chamber device forms a reliable tool for in vitro drug penetration and toxicity studies in isolated perfused corneoscleral tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264136      PMCID: PMC1723919          DOI: 10.1136/bjo.85.4.450

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  IN VITRO ION AND WATER MOVEMENT IN CORNEAS OF RAINBOW TROUT.

Authors:  H F EDELHAUSER; J R HOFFERT; P O FROMM
Journal:  Invest Ophthalmol       Date:  1965-06

2.  Characterization of paracellular penetration routes.

Authors:  D Maurice
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-10       Impact factor: 4.799

3.  A system for long-term corneal perfusion.

Authors:  I Brunette; L R Nelson; W M Bourne
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-08       Impact factor: 4.799

4.  The metabolic basis to the fluid pump in the cornea.

Authors:  S Dikstein; D M Maurice
Journal:  J Physiol       Date:  1972-02       Impact factor: 5.182

5.  Transport of pilocarpine by isolated rabbit cornea.

Authors:  D L Krohn; J M Breitfeller
Journal:  Invest Ophthalmol       Date:  1974-04

6.  Corneal permeability of aldose reductase inhibitor, M79175. I. In vitro study using corneal permeability apparatus.

Authors:  A Kato; Y Ishibashi; Y Miyake; S Iwata
Journal:  J Ocul Pharmacol       Date:  1986

7.  The dynamics of IgG in the cornea.

Authors:  M Allansmith; A de Ramus; D Maurice
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-09       Impact factor: 4.799

8.  The use of fluorescein in ophthalmological research.

Authors:  D M Maurice
Journal:  Invest Ophthalmol       Date:  1967-10

9.  Paracellular permeability of corneal and conjunctival epithelia.

Authors:  A J Huang; S C Tseng; K R Kenyon
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-04       Impact factor: 4.799

10.  The rate of diffusion of fluorophores through the corneal epithelium and stroma.

Authors:  M Araie; D Maurice
Journal:  Exp Eye Res       Date:  1987-01       Impact factor: 3.467

View more
  9 in total

1.  Penetration of engineered antibody fragments into the eye.

Authors:  M A Thiel; D J Coster; S D Standfield; H M Brereton; C Mavrangelos; H Zola; S Taylor; A Yusim; K A Williams
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

Review 2.  In vitro and ex vivo corneal penetration and absorption models.

Authors:  Priyanka Agarwal; Ilva D Rupenthal
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

3.  Influence of format on in vitro penetration of antibody fragments through porcine cornea.

Authors:  H M Brereton; S D Taylor; A Farrall; D Hocking; M A Thiel; M Tea; D J Coster; K A Williams
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

4.  Establishment and characterization of an air-liquid canine corneal organ culture model to study acute herpes keratitis.

Authors:  Rebecca M Harman; Leen Bussche; Eric C Ledbetter; Gerlinde R Van de Walle
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

5.  In vitro biomimetic platforms featuring a perfusion system and 3D spheroid culture promote the construction of tissue-engineered corneal endothelial layers.

Authors:  Shanyi Li; Yuting Han; Hao Lei; Yingxin Zeng; Zekai Cui; Qiaolang Zeng; Deliang Zhu; Ruiling Lian; Jun Zhang; Zhe Chen; Jiansu Chen
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

6.  Epithelial Regeneration in Human Corneas Preserved in an Active Storage Machine.

Authors:  Damien Guindolet; Emmanuel Crouzet; Zhiguo He; Pascal Herbepin; Chantal Perrache; Thibaud Garcin; Anne-Sophie Gauthier; Fabien Forest; Michel Peoc'h; Philippe Gain; Eric Gabison; Gilles Thuret
Journal:  Transl Vis Sci Technol       Date:  2021-02-05       Impact factor: 3.283

Review 7.  Ophthalmic Nanoemulsions: From Composition to Technological Processes and Quality Control.

Authors:  Agnieszka Gawin-Mikołajewicz; Karol P Nartowski; Aleksandra J Dyba; Anna M Gołkowska; Katarzyna Malec; Bożena Karolewicz
Journal:  Mol Pharm       Date:  2021-09-17       Impact factor: 4.939

8.  A Porcine Anterior Segment Perfusion and Transduction Model With Direct Visualization of the Trabecular Meshwork.

Authors:  Ralitsa T Loewen; Pritha Roy; Daniel B Park; Adrianna Jensen; Gordon Scott; Devora Cohen-Karni; Michael P Fautsch; Joel S Schuman; Nils A Loewen
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-03       Impact factor: 4.799

9.  Rapid assessment of ocular drug delivery in a novel ex vivo corneal model.

Authors:  Ghazala Begum; Thomas Leigh; Ella Courtie; Richard Moakes; Gibran Butt; Zubair Ahmed; Saaeha Rauz; Ann Logan; Richard J Blanch
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.